Oncology and Hematology
Episodes 1-16 of 72
Jaffer Ajani, MD
- MinuteCE®
Tailoring First-Line Regimens: Patient-Centric Selection in Metastatic ESCC
0.75 program creditsHarry Yoon, MD
Jaffer Ajani, MD
Harry Yoon, MD
Jaffer Ajani, MD
Harry Yoon, MD
Jaffer Ajani, MD
- MinuteCE®
Effective Monitoring and Management of Adverse Effects in Metastatic ESCC
0.75 program creditsHarry Yoon, MD
Jaffer Ajani, MD
- MinuteCE®
Strategies for Navigating First-Line Treatment Selection in Metastatic ESCC
0.75 program creditsHarry Yoon, MD
Jaffer Ajani, MD
- MinuteCE®
The Importance of PD-L1 Testing: Shaping the Future of Treatment in ESCC
0.75 program creditsHarry Yoon, MD
Harry Yoon, MD
Jaffer Ajani, MD
Daniel P. Petrylak, MD
Elizabeth R. Plimack, MD, MS, FASCO
Evan Y. Yu, MD
Heather McArthur, MD
Margaret Gatti-Mays, MD, MPH
Pasi Antero Jänne, MD, PhD
Helena Yu, MD
Pasi Antero Jänne, MD, PhD
Pasi Antero Jänne, MD, PhD
Helena Yu, MD
- MinuteCE®
Interprofessional Monitoring and Management of AEs With HER3-Directed ADCs
0.75 program creditsHelena Yu, MD
Pasi Antero Jänne, MD, PhD
Helena Yu, MD
Pasi Antero Jänne, MD, PhD
Pasi Antero Jänne, MD, PhD
Helena Yu, MD
- Prev
- Next